PPIB and Hepatitis: We assumed an effect size of 10 percentage points (a 15 vs 5 percentage point increase in the intervention and control areas, respectively) on the basis of a previous study promoting hepatitis B vaccination (23), with an anticipated baseline prevalence of hepatitis B testing of 55% to 70%.